Yes. Niacinamide (nicotinamide, a form of vitamin B3) is one of the more reliably evidenced OTC skincare actives — with published data supporting barrier function, hyperpigmentation, redness, and modest anti-inflammatory effects.
The mechanism is multi-modal. Niacinamide is a precursor to NAD+, which is required for cellular energy metabolism and DNA repair. Topically, it upregulates ceramide synthesis (barrier support), inhibits the transfer of melanosomes from melanocytes to keratinocytes (fading pigmentation), and modulates inflammatory cytokine signaling.
Clinical evidence:
- Hyperpigmentation — Hakozaki's 2002 trial showed measurable reduction in facial hyperpigmentation with 5% niacinamide over 8 weeks (Hakozaki, 2002).
- Barrier function — Bissett's 2005 studies demonstrated improvements in fine lines, blotchiness, and pore appearance with 5% niacinamide (Bissett, 2005).
- Rosacea and redness — modest but real improvement in inflammatory tone.
- Acne — comparable to 1% clindamycin in some head-to-head trials (Shalita, 1995).
Practical: 5-10% concentration, morning or evening, well-tolerated by almost everyone including sensitive skin. Effects appear over 4-8 weeks. Layer freely with vitamin C, retinol, or sunscreen — very few interactions.